Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Dynamic Health Group dba SARMS AMERICA
WARNING LETTER
•Dynamic Health Group dba SARMS AMERICA•November 30, 2025

Dynamic Health Group dba SARMS AMERICA – FDA Warning Letter, Nov 30, 2025

Record Details

On December 12, 2025, the U.S. Food and Drug Administration (FDA) issued a Warning Letter to Dynamic Health Group dba SARMS AMERICA, following a November 2025 review of their website. The FDA found the company unlawfully marketing and distributing selective androgen receptor modulators (SARMs), including "Ostarine MK-2866," "MK-677 Ibutamoren," "Cardarine GW501516," and "LGD-4033 Ligandrol," as unapproved new drugs for sale in the United States. Despite claims of "research use only," the FDA determined that the products" labeling and website content clearly promote them for human use, intending to affect the body"s structure or function, or for disease treatment. This classifies them as "new drugs" under sections 201(g)(1) and 201(p) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), as they are not generally recognized as safe and effective. The introduction of such unapproved drugs into interstate commerce violates sections 301(d) and 505(a) of the FD&C Act, as no FDA approvals exist. The FDA emphasized significant safety concerns associated with SARMs, including life-threatening liver toxicity, heart attack, and stroke risk. Dynamic Health Group is therefore required to cease marketing and distributing these unapproved drug products.

Company
Dynamic Health Group dba SARMS AMERICA
Inspection date
November 30, 2025
Product type
Drugs
Office
Office of Unapproved Drugs & Labeling Compliance
Person
  • Tina Smith (Director)
View Company Profile

ID · 5115bb89-97a2-47d0-9ae2-1f2194dcee6a

Violation Codes10
21 U.S.C. 331(d)FD&C Act 201(p)FD&C Act 505(a)FD&C Act 201(g)(1)21 U.S.C. 321(p)21.U.S.C. 355(a)21 U.S.C. 321(g)(1)FD&C Act 505FD&C Act 301(d)21 CFR 201.128

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dynamic Health Group dba SARMS AMERICA
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.